Your browser doesn't support javascript.
loading
Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion.
Kitamura, Shigeki; Murao, Naoya; Yokota, Shoko; Shimizu, Masaru; Ono, Tomoyuki; Seino, Yusuke; Suzuki, Atsushi; Maejima, Yuko; Shimomura, Kenju.
Afiliación
  • Kitamura S; Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Murao N; Department of Plastic and Reconstructive Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Yokota S; Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Japan.
  • Shimizu M; Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Ono T; Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Seino Y; Department of Neurology, Matsumura General Hospital, Iwaki, Japan.
  • Suzuki A; Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Maejima Y; Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Japan.
  • Shimomura K; Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Japan.
BMC Res Notes ; 16(1): 202, 2023 Sep 11.
Article en En | MEDLINE | ID: mdl-37697384

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fenofibrato Límite: Animals Idioma: En Revista: BMC Res Notes Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fenofibrato Límite: Animals Idioma: En Revista: BMC Res Notes Año: 2023 Tipo del documento: Article País de afiliación: Japón
...